Exact Sciences to Participate in November Investor Conference
MADISON, Wis.--(BUSINESS WIRE)--Nov 1, 2024--
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.
- Jefferies London Healthcare Conference, London
Fireside chat on Tuesday, November 19, 2024 at 6:00 a.m. ET
The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard ® and Oncotype ® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.
View source version on businesswire.com:https://www.businesswire.com/news/home/20241101637242/en/
CONTACT: Erik Holznecht
Exact Sciences Corp.
investorrelations@exactsciences.com
608-800-6605
KEYWORD: WISCONSIN UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: ONCOLOGY HEALTH MEDICAL DEVICES HEALTH TECHNOLOGY OTHER HEALTH GENERAL HEALTH BIOTECHNOLOGY
SOURCE: Exact Sciences Corp.
Copyright Business Wire 2024.
